Pancreatic Cancer Research

ResearcherOsaka City UniversityActive in the last 2 years

Norifumi Kawada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6392-8311; OpenAlex author ID A5024647870. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. The Impact of Peroxiredoxin 3 on Molecular Testing, Diagnosis, and Prognosis in Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17132212↗
  2. Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. Last author DOI 10.1038/s41389-022-00389-4↗
  3. Pancreatic Cancer Cell Fraction Estimation in a DNA Sample. Co-author DOI 10.1159/000491637↗
  4. New player in tumor-stromal interaction: Granulin as a novel therapeutic target for pancreatic ductal adenocarcinoma liver metastasis. First author DOI 10.1002/hep.28849↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yuko Kuwae · 1 shared paper, 2025 · strength 0.22
  2. Anna Kakehashi · 1 shared paper, 2025 · strength 0.22
  3. Hideki Wanibuchi · 1 shared paper, 2025 · strength 0.22
  4. Kenjiro Kimura · 2 shared papers, 2018–2022 · strength 0.20
  5. Misako Sato‐Matsubara · 1 shared paper, 2017 · strength 0.15
  6. Dinh Viet Hoang · 1 shared paper, 2022 · strength 0.12
  7. Shoji Kubo · 1 shared paper, 2022 · strength 0.12
  8. Ryosuke Amano · 1 shared paper, 2018 · strength 0.07
  9. Hiroki Ishihara · 1 shared paper, 2018 · strength 0.07
  10. Kosei Hirakawa · 1 shared paper, 2018 · strength 0.07
  11. Toshikazu Ushijima · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.